Attackers are looking to the healthcare space as a rich repository of intellectual property (IP) now more than ever, as critical research of COVID-19 therapeutics are developed and Pfizer, Moderna and other biotech firms begin to mass produce vaccines. Several incidents show that nation-states are targeting these companies with a vengeance, as the quest to beat the pandemic continues.
Espionage attacks have recently zeroed in on the COVID-19 vaccine supply chain, The Zebrocy malware continues to be used by hackers in vaccine-related cyberattacks. And earlier this month, threat actors accessed Pfizer and BioNTech vaccine documentation submitted to EU regulators.
